Head and neck cancers comprise 4% of the cancer burden in the United States each year. Many types of head and neck cancers present as an asymptomatic, nontender neck mass or nonspecific symptoms, such as hoarseness, sore throat, and pain. Head and neck cancers are frequently diagnosed incidentally by the primary care physician or dentist. This review summarizes the epidemiology, clinical manifestations, diagnosis, and treatment of several common head and neck cancers in order to provide an increased awareness for the internist to facilitate early detection of these diseases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.mcna.2018.06.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Impact of Asthma on Quality of Life of Children With Chronic Rhinosinusitis.
Int Forum Allergy Rhinol
March 2025
Department of Otolaryngology-Head and Neck Surgery, West Virginia University, Morgantown, West Virginia, USA.
Retraction Note: Brief literature review and comprehensive bioinformatics analytics unravel the potential mechanism of Curcumin in the treatment of periodontitis.
BMC Oral Health
March 2025
Department of Oral and Maxillofacial-Head and Neck Oncology, College of Stomatology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
The effect of 5% and 10% povidone-iodine antiseptic concentrations on postoperative sensorineural hearing loss in tympanoplasty: a triple-blind randomized clinical trial.
Eur Arch Otorhinolaryngol
March 2025
Otolaryngology Research Center, Department of Otolaryngology-Head and Neck Surgery, Tehran University of Medical Sciences, Imam Khomeini Medical Complex, Tehran, Iran.
Purpose: To evaluate the ototoxicity of povidone iodine (PVP-I) at concentrations of 5% and 10% during tympanoplasty by assessing frequency-specific audiometric outcomes and graft success rates in a large cohort of patients.
Methods: This prospective, triple-blinded, randomized clinical trial enrolled 542 patients undergoing primary tympanoplasty. After excluding patients for inadequate follow-up, 204 ears received 10% PVP-I and 199 ears received 5% PVP-I.
Oligometastatic Head and Neck Squamous Cell Carcinoma: Is SABR the Solution?
Int J Radiat Oncol Biol Phys
April 2025
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!